IGC Pharma (IGC) Equity Income (2011)
IGC Pharma (IGC) recorded Equity Income of $317,742 in FY2017.
Powered by 
Analysis
IGC Pharma (IGC) Equity Income (2011) Analysis & Trends
- Annual Equity Income has a five-year compound annual growth rate of 62.0% (FY2012 to FY2017).
- The FY2017 figure is the lowest annual Equity Income since FY2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.24 Bn | 1,102.83 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 616.11 Bn | 534.64 Bn | 17.26 Bn | - |
| 3 | AbbVie | 501.21 Bn | 474.32 Bn | 12.70 Bn | - |
| 4 | Merck | 367.51 Bn | 321.89 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.95 Bn | 261.94 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 235.88 Bn | 191.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.74 Bn | 164.94 Bn | 6.22 Bn | - |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | - |
| 10 | IGC Pharma | 24.44 Mn | 21.69 Mn | 55,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | -33,588.00 |
| Sep 30, 2011 | 25,832.00 |
| Jun 30, 2011 | 36,219.00 |
API Access
IGC Pharma Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();